National Resilience, Inc. is a technology-focused biomanufacturing company founded in 2020 to broaden access to complex medicines and strengthen biopharmaceutical supply chains. It operates an end-to-end manufacturing network across North America, supporting development and production of medicines from early phase through commercial manufacturing. Its facilities produce drug substances and drug products, including cell therapies and vaccines.
Good Manufacturing Practice (GMP)
Compliance program
USFDA cGMP
Compliance program
USFDA Pre-Approval Inspection (PAI)
Compliance program
USFDA PFS and vial approval
Compliance program
Health Canada inspection
Compliance program
EMA virtual inspection
Compliance program
EU Annex 1 assessment
Compliance program
GMP
Quality certification
FDAPAI
Quality certification
FDA
Quality certification
Emergent BioSolutionsFounded in 1998 to supply the U.S. government with anthrax vaccine, Emergent BioSolutions develops and manufactures medical countermeasures and other protective products for biological threats and opioid overdose emergencies. The company also operates as a strategic manufacturing partner, using specialized containment capabilities across four North American facilities to help biopharma companies, governments and nonprofits develop and make complex biological products. Its commercial portfolio includes NARCAN® Nasal Spray alongside preparedness products for threats such as anthrax, smallpox and botulism.ROCKVILLE, MD
Emergent BioSolutionsEmergent BioSolutions is a public health company that develops and manufactures protective medicines and medical countermeasures for opioid overdose emergencies and biological threats. Founded in 1998, it began by partnering with the U.S. government to supply an anthrax vaccine and now operates manufacturing facilities across the United States and Canada, alongside research and development and commercial product operations.325412PLYMOUTH MEETING, PA
BioFactura, IncFounded in Frederick in 2004, BioFactura develops and manufactures biosimilars, biodefense medical countermeasures, and other biologic medicines using its patented StableFast biomanufacturing platform. The clinical-stage company has advanced programs for a smallpox therapeutic and a proposed ustekinumab biosimilar, while its Capitol Biologics division provides development and early-phase clinical manufacturing support to emerging biotech firms and government agencies.FREDERICK, MD
Eli Lilly and CompanyEli Lilly and Company is a pharmaceutical company that researches, develops, and manufactures medicines, with a history of making medicine spanning 150 years. Its manufacturing network produces medicines and active pharmaceutical ingredients, as well as delivery devices, and the company says it has launched 21 new medicines since 2014. Lilly is expanding production capacity across facilities in the United States and internationally to supply its medicines to patients around the world.PHILADELPHIA, PA